[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Daiichi Sankyo Company Limited
Daiichi Sankyo's lung cancer treatment secures FDA approval, but legal issues surrounding the Fortis acquisition are causing social media buzz.
About Daiichi Sankyo Company Limited
Daiichi Sankyo Company Limited is a global pharmaceutical company.
Insights #
- Daiichi Sankyo Company Limited mentions is at XX which is XXX% higher than it's daily average.
- Daiichi Sankyo Company Limited creators is at XX which is XXX% higher than it's daily average.
- Daiichi Sankyo Company Limited sentiment is up XXXXX% from the previous week.
- Daiichi Sankyo Company Limited posts created is up XXXXXX% from the previous week.
Price: $ #
Price 24-Hour Chart Data
The price action is likely uncertain due to mixed sentiment. Positive news regarding the lung cancer treatment approval is balanced by negative sentiment related to the Fortis acquisition dispute.
1-Year High: $XXXXX on 2024-10-30
1-Year Low: $XXXXX on 2025-04-17
AltRank: undefined #
AltRank 24-Hour Chart Data
Daiichi Sankyo Company Limited is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2025-03-10
1-Year Low: XXX on 2025-01-21
Galaxy Score: XX #
Galaxy Score 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-25
1-Year Low: XX on 2024-09-01
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX +370%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +491%
1-Year High: XXXXXXX on 2024-09-12
1-Year Low: X on 2024-07-24
| Social Network | YouTube | X | News | |
|---|---|---|---|---|
| Engagements | XXX | XXX | X | X |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: XX
1 Week: XX +7.60%
1 Month: XXX +11%
6 Months: XXX +66%
1 Year: XXX +79%
1-Year High: XX on 2025-07-04
1-Year Low: X on 2024-07-24
| Social Network | YouTube | X | News | |
|---|---|---|---|---|
| Mentions | XX | XX | X | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Daiichi Sankyo Company Limited in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XX
1 Week: XX -XXXX%
1 Month: XXX +5.30%
6 Months: XXX +63%
1 Year: XXX +78%
1-Year High: XX on 2025-07-04
1-Year Low: X on 2024-07-24
The most influential creators that mention Daiichi Sankyo Company Limited in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @daiichisankyous | X | XXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +33%
1 Month: XX% +24%
6 Months: XX% -X%
1 Year: XX% -X%
1-Year High: XXX% on 2024-07-29
1-Year Low: XX% on 2025-05-23
Most Supportive Themes
- Cancer Treatment Innovation: (35%) Daiichi Sankyo is presenting data at ASCO and collaborating on trials, indicating innovation in cancer treatment.
- COVID-19 Related Gains: (25%) Rising COVID cases in Asia are correlated with increased interest in related stocks, potentially benefiting Daiichi Sankyo.
Most Critical Themes
- Fortis Acquisition Dispute: (30%) Legal disputes regarding the Fortis Healthcare acquisition are creating negative sentiment.
- Negative Sentiment: (10%) Some social media sentiment expresses negativity towards the company.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| YouTube | XXX | XX% | XX | X% | XXX | XX% |
| X | XXX | XX% | XXX | XX% | X | X% |
| X | X% | X | X% | X | X% | |
| News | X | X% | X | X% | X | X% |
| Total | XXX | XX% | XXX | XX% | XXX | XX% |
Market Cap: $undefined #
Market Cap 24-Hour Chart Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXXXXX on 2024-07-31
1-Year Low: $XXXXXXXXXXXXXXXXX on 2025-02-20
Top assets mentioned In the posts about Daiichi Sankyo Company Limited in the last XX hours
Pfizer, Inc. (PFE) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK)
Top topics mentioned In the posts about Daiichi Sankyo Company Limited in the last XX hours
$6417t, $8750t, lexicon, $084990kq, drugs, coins healthcare, $baynsg, roadmap, stocks, tariffs, cnbc, espr, $espr, careers, investment, crafts, sustainability, $47m, $pfe, manat, $45m, breakthrough, $azn, stocks healthcare, $mrk, auction, market cap, $2269t, $8986t, $8601t, lever, $7974t, $capa, $telnf, stack, money, 1b, nct, johnson and johnson, japan, $4507t, $4523t, astellas pharma, longterm, nxt, $onexf
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Daiichi Sankyo struck gold with ADC cancer drugs. Its new CEO has to figure out whats next. via @BioPharmaDive"
@Abbeyandsmokey on X 2025-07-22 17:39:51 UTC XXX followers, X engagements
"Otsuka Holdings :July XX 2025 13:30 JST 2Q/FY2025 Financial Results Daiichi Sankyo FY2025 Q1 Financial Results (Available after July XX 1:00 pm JST) and $ESPR just after a bit earlier"
@MACROVET888 on X 2025-07-22 13:10:29 UTC XXX followers, XXX engagements
"Ray Bedeaux turns complexity into impact. His craft "Synthesis" ensures the critical medicines we create reach patients who need them most. Share your unique craft below and how it is shaping the future. Read our Company Brochure to learn how we are making an impact:"
@DaiichiSankyoUS on X 2025-07-21 14:59:12 UTC 4383 followers, XXX engagements
"Were delighted to announce that Laura McMullin General Manager at Daiichi Sankyo UK will be the ABPIs new Vice-President. Laura will work alongside the ABPI President and Board to help deliver the ABPIs priorities"
@ABPI_UK on X 2025-07-21 14:44:47 UTC 17.4K followers, XXX engagements